Opinion/decision on a Paediatric investigation plan (PIP): Methylphenidate (hydrochloride), decision type: , therapeutic area: , PIP number: P/0057/2023

Opinion/decision on a Paediatric investigation plan (PIP): Methylphenidate (hydrochloride), decision type: , therapeutic area: , PIP number: P/0057/2023

Opinion/decision on a Paediatric investigation plan (PIP): Human, recombinant, non-fucosylated IgG1k monoclonal antibody targeting OX-40 receptor on activated T cells (rocatinlimab), decision type: , therapeutic area: , PIP number: P/0017/2023

Opinion/decision on a Paediatric investigation plan (PIP): Human, recombinant, non-fucosylated IgG1k monoclonal antibody targeting OX-40 receptor on activated T cells (rocatinlimab), decision type: , therapeutic area: , PIP number: P/0017/2023

Opinion/decision on a Paediatric investigation plan (PIP): Evoncabtagene pazurgedleucel, decision type: , therapeutic area: , PIP number: P/0016/2023

Opinion/decision on a Paediatric investigation plan (PIP): Evoncabtagene pazurgedleucel, decision type: , therapeutic area: , PIP number: P/0016/2023

Opinion/decision on a Paediatric investigation plan (PIP): Neisseria meningitidis serogroup B fHbp subfamily A,Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid carrier protein,Neisseria meningitidis serogroup B fHbp subfamily B,

Opinion/decision on a Paediatric investigation plan (PIP): Neisseria meningitidis serogroup B fHbp subfamily A,Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid carrier protein,Neisseria meningitidis serogroup B fHbp subfamily B,Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid carrier protein,Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid carrier protein,Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid carrier protein (MenABCWY), decision type: , therapeutic area: , PIP number: P/005

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative;Crohn Disease, Date of authorisation: 22/05/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative;Crohn Disease, Date of authorisation: 22/05/2014, Revision: 25, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Respiratory syncytial virus stabilised prefusion F subunit vaccine, decision type: , therapeutic area: , PIP number: P/0058/2023

Opinion/decision on a Paediatric investigation plan (PIP): Respiratory syncytial virus stabilised prefusion F subunit vaccine, decision type: , therapeutic area: , PIP number: P/0058/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.